Melanoma is a highly aggressive form of skin cancer with a very poor prognosis and
excessive resistance to current conventional treatments. Recently, the application of the …

Melanoma is a progressive disease that claims many lives each year due to lack of
therapeutics effective for the long‐term treatment of patients. Currently, the best treatment …

In the development of cancer chemotherapy, besides the discovery of new anticancer drugs,
a variety of nanocarrier systems for the delivery of previously developed and new …

Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases
expected for 2040. Despite de advances in the treatment, it remains a challenge because of …

Nano-drug delivery systems have opened new pathways for tumor treatment by overcoming
some of the limitations of conventional drugs, such as physiological degradation, short half …

The limitations of conventional cancer treatment are driving the emergence and
development of nanomedicines. Research in liposomal nanomedicine for cancer therapy is …

Purpose Melanoma is the most aggressive form of skin cancer. Chemotherapy at a late
stage fails due to low accumulation in tumors, indicating the need for targeted therapy …

Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such
as liposomes, have favorable advantages with the potential to further improve cancer …

Published literature on cancer by health agencies and health organizations reveals
increased cancer incidence year by year. The first line of cancer treatment involves one or …

In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …